Inflammatory Signaling Linked to Leukemia Progression
An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.
Emerging Therapy for Relapsed Lymphoma
An emerging therapy showed promise in patients with relapsed B-cell lymphoma who are not ideal candidates for stem cell transplants.
A new study has identified a molecular switch, through a protein called CDK9, that plays an early and critical role in the skin stem cell differentiation process.